Clinical trial for Oral Squamous Cell Carcinoma
Official title Epigenetic Biomarkers in the Saliva for the Diagnosis of Squamous Cells Carcinoma of the Oral Cavity
ClinicalTrials.gov ID: NCT05791149
What this study is testing
- What it's testing
- Head and neck squamous cell carcinoma (HNSCC) are malignant tumors originating from the epithelial mucosa of the upper aerodigestive tract. The oral cavity is the most frequent location of HNSCC (oral squamous cell carcinoma: OSCC).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient group:
- Patients from the maxillofacial surgery department treated for a histologically confirmed squamous cell carcinoma of the oral cavity
- Patients whose first-line treatment decision at the multidisciplinary meeting in the service of Maxillofacial Surgery is surgery
- Patients who have not yet been treated surgically or by neoadjuvant treatment
- Patients over 18 years old
You likely can't join if
- Patients with other types of cancer
- Patients under the age of 18
- Pregnant or breastfeeding women
- Patients under guardianship, curators, legal protection or deprived of liberty
See the full eligibility criteria
- Patient group:
- Patients from the maxillofacial surgery department treated for a histologically confirmed squamous cell carcinoma of the oral cavity
- Patients whose first-line treatment decision at the multidisciplinary meeting in the service of Maxillofacial Surgery is surgery
- Patients who have not yet been treated surgically or by neoadjuvant treatment
- Patients over 18 years old
- Patients who have provided free and informed consent in writing
- Patients benefiting from a social security scheme Control group:
- Patients in the maxillofacial surgery department not covered for head and neck cancer
- Patients over 18 years old
- Patients who have provided free and informed consent in writing
- Patients benefiting from a social security scheme
- Control group homogeneous with the patient group according to age, sex, tobacco and alcohol consumption
- Patients with other types of cancer
- Patients under the age of 18
- Pregnant or breastfeeding women
- Patients under guardianship, curators, legal protection or deprived of liberty
The study team makes the final eligibility decision.
Where it's taking place
- Amiens, Picardie, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Amiens, Picardie, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.